FDA vaccine chief to leave the agency again
Source: SeekingAlpha
2026-03-07 07:41:45 ET
More on Pfizer, Johnson & Johnson, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- The Sun Will Shine On Moderna Again - Initiating With A Buy
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom
- J&J subsidiaries ink $65M deal to resolve Tracleer antitrust case
- Pharma giants pressed by Senate Democrats over Trump pricing deals
Read the full article on Seeking Alpha
For further details see:
FDA vaccine chief to leave the agency again
Sarepta Therapeutics Inc.
NASDAQ: SRPT
SRPT Trading
1.56% G/L:
$17.885 Last:
1,151,803 Volume:
$17.63 Open:
SRPT Latest News
February 27, 2026 09:00:00 am
Sarepta Therapeutics Announces Call for Applications for the 9th Annual Route 79, The Duchenne Scholarship Program
SRPT Stock Data
$1,921,797,010
96,823,361
N/A
132
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
